News
The future of telehealth is trust, combined with patient education. As the market matures, all parties — providers, ...
Roche said it will expand existing sites and construct new U.S. manufacturing and R&D infrastructure in areas such as gene ...
The healthcare industry has faced a flurry of sweeping changes at the federal level since President Donald Trump took office. In recent months, healthcare leaders have scrambled to come up with ...
In today’s healthcare landscape, organizations that communicate effectively with their patients positively impact both satisfaction and outcomes. In fact, quality communication between patients ...
The nursing workforce crisis has improved slightly since the pandemic, but it’s far from over. New research from the National Council of State Boards of Nursing (NCSBN) shows that nurses are ...
UnitedHealth Group took quite the tumble on Thursday and Medicare Advantage troubles seem to largely be at fault. Its shares fell by over 22% after its first quarter earnings on Thursday.
A cancer drug from partners AstraZeneca and Daiichi Sankyo currently approved as a second-line or later treatment for metastatic breast cancer has interim clinical data showing it helped patients ...
In anticipation of the next major global pandemic, it is paramount that the global response to the Covid-19 pandemic is assessed. Especially now, as we see more diseases emerging in both ...
Sanofi and Regeneron Pharmaceuticals drug Dupixent has won FDA approval for chronic spontaneous urticaria, introducing a new approach to the treatment of this inflammatory skin disorder.
Aeroflow Health, a health tech company, last week announced a new diabetes management program, which aims to improve adherence, outcomes and care coordination for health plan members. Asheville ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results